Literature DB >> 28960561

Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.

Makoto Ito1, Takeshi Kodaira1, Hiroyuki Tachibana1, Natsuo Tomita1, Chiyoko Makita1, Yutaro Koide1, Daiki Kato1, Tetsuya Abe2, Kei Muro3, Masahiro Tajika4, Yasumasa Niwa4, Yasuhisa Hasegawa5.   

Abstract

BACKGROUND: The efficacy of intensity-modulated radiotherapy (IMRT) for cervical esophageal cancer has not been determined.
METHODS: Eighty patients with cervical esophageal cancer treated with definitive chemoradiotherapy from 2002 to 2014 were analyzed. Overall survival (OS), failure patterns, and toxicity incidence were compared between the IMRT (N = 32) and 3D conformal radiotherapy (RT; N = 48) groups.
RESULTS: The median follow-up was 35.9 months. The 3-year OS of the IMRT, 3D conformal RT, and total groups was 81.6%, 57.2%, and 66.6%, respectively. Pulmonary toxicity was not observed with IMRT. Six of 62 cases (9.6%) with nodal involvement developed upper cervical node recurrence outside the prophylactic region. Ten patients in the IMRT group were salvaged, and 60% survived without recurrence; 20% of the 3D conformal RT group was salvaged.
CONCLUSION: The IMRT group was comparable with 3D conformal RT group, with a better salvage rate. We recommend extended cervical irradiation for nodal involvement.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cervical esophageal cancer; clinical results; definitive chemoradiotherapy; failure pattern; intensity-modulated radiotherapy (IMRT)

Mesh:

Year:  2017        PMID: 28960561     DOI: 10.1002/hed.24909

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

Review 1.  Cervical Esophageal Cancers: Challenges and Opportunities.

Authors:  Michael Buckstein; Jerry Liu
Journal:  Curr Oncol Rep       Date:  2019-04-04       Impact factor: 5.075

2.  Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer.

Authors:  Hiroshi Okamoto; Yusuke Taniyama; Tadashi Sakurai; Takahiro Heishi; Jin Teshima; Chiaki Sato; Shota Maruyama; Ken Ito; Yu Onodera; Takuro Konno-Kumagai; Hirotaka Ishida; Takashi Kamei
Journal:  Esophagus       Date:  2018-06-15       Impact factor: 4.230

3.  Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis.

Authors:  Armando De Virgilio; Andrea Costantino; Carlo Castoro; Giuseppe Spriano; Bianca Maria Festa; Giuseppe Mercante; Davide Franceschini; Ciro Franzese; Marta Scorsetti; Andrea Marrari; Raffaele Cavina; Salvatore Marano
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-02       Impact factor: 4.553

4.  Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.

Authors:  Nai-Bin Chen; Bo Qiu; Jun Zhang; Meng-Yun Qiang; Yu-Jia Zhu; Bin Wang; Jin-Yu Guo; Ling-Zhi Cai; Shao-Min Huang; Meng-Zhong Liu; Qun Li; Yong-Hong Hu; Qi-Wen Li; Hui Liu
Journal:  Cancer Res Treat       Date:  2019-04-30       Impact factor: 4.679

5.  Radiation-induced acute injury of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a prospective cohort study.

Authors:  Zexin Yao; Bing Zhang; Jialin Huang; Lei Shi; Biao Cheng
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

6.  Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy.

Authors:  Taiki Takaoka; Natsuo Tomita; Tomoki Mizuno; Shingo Hashimoto; Takahiro Tsuchiya; Masashi Tomida; Takeshi Yanagi
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

7.  The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study.

Authors:  Jing Hu; Zhe Chen; Jiaming Lv; Zhen Zheng; Yanping Bei; Xue Chen; Lu Zheng; Wenjie Song; Yunbao Xu
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

8.  Definitive Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil for Advanced Cervical Esophageal Cancer: A Medium-Term Outcome.

Authors:  Hiroshi Okamoto; Yusuke Taniyama; Chiaki Sato; Toshiaki Fukutomi; Yohei Ozawa; Ryohei Ando; Kozue Takahashi; Ryujiro Akaishi; Yuta Horie; Yasuharu Shinozaki; Michiaki Unno; Takashi Kamei
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

9.  Efficacy of virtual block objects in reducing the lung dose in helical tomotherapy planning for cervical oesophageal cancer: a planning study.

Authors:  Makoto Ito; Hidetoshi Shimizu; Takahiro Aoyama; Hiroyuki Tachibana; Natsuo Tomita; Chiyoko Makita; Yutaro Koide; Daiki Kato; Tsuneo Ishiguchi; Takeshi Kodaira
Journal:  Radiat Oncol       Date:  2018-04-04       Impact factor: 3.481

10.  Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.

Authors:  Makoto Ito; Takeshi Kodaira; Yutaro Koide; Takahito Okuda; Shinichiro Mizumatsu; Yukihiko Oshima; Arisa Takeuchi; Toshie Mori; Souichirou Abe; Ayumi Asai; Kojiro Suzuki
Journal:  BMC Cancer       Date:  2020-06-09       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.